SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
21-Aug-24 6:38 PM View: | Quince Therapeutics, Inc. (QNCX) | 21-Aug-24 | Purchase | 30,845 | $0.63 | $19,336.80 | 12% 265.69K to 296.54K | |
21-Aug-24 6:38 PM View: | Quince Therapeutics, Inc. (QNCX) | 20-Aug-24 | Purchase | 5,924 | $0.60 | $3,579.40 | 2% 259.77K to 265.69K | |
21-Aug-24 6:38 PM View: | Quince Therapeutics, Inc. (QNCX) | 19-Aug-24 | Private Purchase | 2,155 | $0.58 | $1,249.90 | < 1% 257.62K to 259.77K | |
05-Jun-24 2:37 PM View: | Quince Therapeutics, Inc. (QNCX) | 04-Jun-24 | Option Exercise | 56,061 | $0.55 | $30,833.60 | 28% 201.56K to 257.62K | |
09-Aug-23 6:21 PM View: | Quince Therapeutics, Inc. (QNCX) | 08-Aug-23 | Private Purchase | 71,762 | $1.22 | $87,549.60 | 55% 129.79K to 201.56K | |
23-May-22 8:07 PM View: | Quince Therapeutics, Inc. (QNCX) | 19-May-22 | Grant | 16,224 | -- | -- | 100% 0 to 16.22K |